Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-11-056353)

Filing Details

Accession Number:: 0001140361-11-056353
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-12-06 16:59:39
Reporting Period:: 2011-12-05

Filing Date:: 2011-12-06
Accepted Time:: 2011-12-06 16:59:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
69499	Mylan Inc.	MYL	Pharmaceutical Preparations (2834)	251211621

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197539	L Randall Vanderveen	1500 Corporate Drive Canonsburg PA 15317		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-12-05	16,875	$13.60	34,527	No	4	M	Direct
Common Stock	Disposition	2011-12-05	16,875	$19.88	17,652	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Employee Director Stock Option Right to Buy	Disposition	2011-12-05	16,875	$0.00	16,875	$13.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2003-03-01	2012-03-01	No	4	M	Direct

Footnotes

As disclosed in the Company's Form 10-Q for the quarter ended September 30, 2011, Dr. Vanderveen's stock options were among those held by directors that were set to expire in 2012, in this case in early March.
Represents the weighted price of the reporting person's disposition of 16,875 shares in transactions ranging from $19.87 to $19.89 per share.